EP0052510B2 — Microencapsulation of water soluble polypeptides
Assigned to Syntex USA LLC · Expires 1994-10-19 · 32y expired
What this patent protects
This invention concerns novel sustained release microcapsule compositions comprising water-soluble, hormonally active polypeptides and optionally, a polymer hydrolysis modifying agent encapsulated in biocompatable, biodegradable polymers such as poly(lactide-co-glycolide) copoly
USPTO Abstract
This invention concerns novel sustained release microcapsule compositions comprising water-soluble, hormonally active polypeptides and optionally, a polymer hydrolysis modifying agent encapsulated in biocompatable, biodegradable polymers such as poly(lactide-co-glycolide) copoly
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.